Torkler, Sandra M. Sc.

Group Manager Bioprocess Scale-up

Sandra Torkler is a trained biotechnologist with 10 years of experience as a scientist in the field of scaling bioprocesses in collaboration with academia and industry. Since July 2022 she is group manager of the Bioprocess Scale-up group at Fraunhofer CBP

  • Professional career

    Since 07/2022 Group Manager Bioprocess Scale-up at Fraunhofer CBP
    04/2013 – 06/2022 Project manager Bioprocess Scale-up at Fraunhofer CBP
    04/2006 – 03/2013 MTLA at Probiodrug AG
    10/2003 – 03/2006 MTLA at ACGT Progenomics AG
    08/2002 – 09/2003 MTLA at Vectron Therapeutics AG 
    10/2008 – 09/2013 Studies in Biotechnology at Anhalt University of Applied Sciences 
    08/1999 – 07/2002 Apprenticeship MTLA (Medical Technical Laboratory Assistant)
  • Project title Project title long Funding source Period
    UNRAVEL UNRAVEL – UNique Refinery Approach to Valorise European Lignocellulosics JU June 2018 – May  2021
    2GEnzymes 2GEnzymes – Enzymes for 2G Sugars BMBF June 2016 – May 2019
    KomBiChemPro KomBiChemPro – fine and platform chemicals from wood by combined chemical‑biotechnological processes BMBF November 2015 – May 2018
    Bio‑Solketal  Bio‑Solketal – Synthesis of 100 percent bio‑based Solketal (Isopropylidene glycerol) BMBF September 2014 – June 2017
    Integrated Bioproduction Integrated Bioproduction – Integrated chemical‑biotechnological production of building blocks on the basis of renewable resources in a biorefinery BMELV May 2009 – April 2012
  • Further publications

    Navarrete Santos A, Torkler S, Nowak D, Schlittig C, Goerdes M, Lauber T, Trischmann L, Schaupp M, Penz M, Tiller FW, Böhm G., „Detection of amyloid-beta oligomers in human cerebrospinal fluid by flow cytometry and fluorescence resonance energy transfer.” J Alzheimers Dis. 2007; 11(1): 117-25. doi: 10.3233/jad-2007-11114

    Trieschmann L, Navarrete Santos A, Kaschig K, Torkler S, Maas E, Schätzl H, Böhm G., „Ultra-sensitive detection of prion protein fibrils by flow cytometry in blood from cattle affected with bovine spongiform encephalopathy.” BMC Biotechnol. 2005; 5: 26. doi: 10.1186/1472-6750-5-26